Latest Revenue Forecast News

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

4DMedical has responded to ASX queries over its FY2025 financial report, clarifying assumptions behind intangible asset valuations and addressing the auditor’s qualified opinion.

Antilles Gold Limited has released an updated financial analysis for its Nueva Sabana copper-gold mine in Cuba, highlighting improved project economics and a construction start slated for late 2025. The study reflects higher metal prices and revised costs, underpinning a strong net profit and positive cash flow outlook.

COSOL Limited reports a $7-8 million revenue shortfall in H1 FY26 amid macroeconomic pressures but pivots towards higher-margin Asset Management as a Service contracts and cost efficiencies to stabilize performance.

icetana Limited reports its strongest quarterly growth yet, driven by a strategic partnership with SoftBank Robotics that has propelled annual recurring revenue to $2.3 million.

Vitasora Health is set to scale its AI-powered chronic care services from Hawaii to 10-15 US states, leveraging a new partnership with Privia Health following Evolent Care Partners' divestiture. This expansion targets up to 30,000 patients and promises significant revenue growth in 2026.

Findi Limited updates FY26 guidance with over A$100 million revenue forecast, announces acquisition of Sphere loyalty platform, and advances IPO plans on Bombay Stock Exchange.

NRW Holdings has completed its acquisition of Fredon Industries, integrating 2,500 new employees and enhancing its electrical and mechanical services portfolio. The company has updated its FY26 guidance, projecting revenue above $4 billion and underlying EBITA between $255 million and $265 million.

Electro Optic Systems updates its 2025 revenue outlook to $115-125 million from existing contracts, with potential for an additional $25 million from new orders. The company’s contract backlog has jumped to $299 million, reflecting strong demand despite some delays in contract signings.

Wellnex Life has secured a significant opening order from global partner Haleon for its Liquid Paracetamol and Ibuprofen softgel products in the UAE, marking the fourth national market in Haleon's distribution network. This milestone supports Wellnex's revenue forecasts for 2025 and underscores its strategic focus on innovative healthcare products.

PainChek’s UK pilot reveals significant clinical improvements and economic benefits, positioning the digital pain assessment app for broader adoption in Scotland and beyond.

Zeotech Limited has locked in a binding five-year offtake agreement with MSI, granting exclusive marketing rights for its kaolin products across key Asian markets. This deal, valued at approximately AUD 204 million, sets the stage for early cash flow generation and advancement of its low-carbon concrete additive project.